| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-08 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.37 | 2e-07 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.37 | 3e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.21 | 5e-05 |